S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/RTW Investments/Q4 2020

RTW Investments

Periodo: Q4 2020 Β· Depositato: 2021-02-16
Vedi su SEC EDGAR β†—
AUM
$5.96B
Valore totale del portafoglio
Posizioni
102
Titoli dichiarati
Prima Posizione
RCKT
15.7% $935.6M
Var. Trimestrali
+8 / -8
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2021-02-16) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
RCKTRocket Pharmaceuticals Inc$935.6M15.70%$54.84$3.84-93.0%
15.7%
IMVTImmunovant Inc$350.7M5.88%$46.19$38.79-16.0%
5.9%
PTCTPTC Therapeutics Inc$257.7M4.32%$61.03$83.31+36.5%
4.3%
MRTXMirati Therapeutics Inc$231.6M3.89%β€”β€”
3.9%
STOKStoke Therapeutics Inc$219.5M3.68%$61.93$32.70-47.2%
3.7%
ALNYAlnylam Pharmaceuticals Inc$218.6M3.67%$129.97$312.78+140.7%
3.7%
NTRANatera Inc$170.4M2.86%$99.52$279.32+180.7%
2.9%
DRNADicerna Pharmaceuticals Inc$159.8M2.68%β€”β€”
2.7%
ARVNArvinas Inc$152.1M2.55%$84.93$8.39-90.1%
2.5%
VCELVericel Corp$139.5M2.34%$30.88$46.98+52.1%
2.3%
AXSMAxsome Therapeutics Inc$136.3M2.29%$81.47$244.31+199.9%
2.3%
ILMNIllumina Inc$133.9M2.25%$359.92$188.68-47.6%
2.3%
CERNCerner Corp$133.6M2.24%β€”β€”
2.2%
MASIMasimo Corp$126.0M2.11%$268.38β€”
2.1%
GMEDGlobus Med Inc$107.0M1.80%$65.22$80.12+22.9%
1.8%
RNAMAvidity Biosciences Inc$102.0M1.71%β€”β€”
1.7%
TARSTarsus Pharmaceuticals Inc.$99.0M1.66%$41.33$65.44+58.3%
1.7%
AXNXAxonics Modulation Technolog$94.0M1.58%β€”β€”
1.6%
DMTKQDermTech Inc$93.7M1.57%β€”β€”
1.6%
TXG10x Genomics Inc$93.6M1.57%$141.60$39.01-72.5%
1.6%
ATHAAthira Pharma Inc$88.9M1.49%β€”β€”
1.5%
ESTAEstablishment Labs Hldgs Inc$87.3M1.46%$37.64$89.25+137.1%
1.5%
FREQFrequency Therapeutics Inc$86.8M1.46%β€”β€”
1.5%
ADVMAdverum Biotechnologies Inc$78.3M1.31%β€”β€”
1.3%
GHGuardant Health Inc$75.0M1.26%$128.88$167.98+30.3%
1.3%
LUNGPulmonx Corp$74.8M1.26%$69.02$1.39-98.0%
1.3%
PTGXProtagonist Therapeutics Inc$73.6M1.23%$20.16$131.62+552.9%
1.2%
CCCCC4 Therapeutics Inc$68.7M1.15%$33.13$4.30-87.0%
1.1%
TNDMTandem Diabetes Care Inc$63.2M1.06%$95.68$15.32-84.0%
1.1%
CLDXCelldex Therapeutics Inc New$60.0M1.01%$17.52$38.37+119.0%
1.0%

AttivitΓ  Trimestre su Trimestre

Q4 2020 vs. Q3 2020

Nuove Posizioni (8)

TickerEmittenteNozionaleDal Deposito
ARVNArvinas Inc$152.1M-90.1%
GMEDGlobus Med Inc$107.0M+22.9%
TARSTarsus Pharmaceuticals Inc.$99.0M+58.3%
LUNGPulmonx Corp$74.8M-98.0%
CCCCC4 Therapeutics Inc$68.7M-87.0%
KURAKura Oncology Inc$55.6M
FPRXFive Prime Therapeutics Inc$42.8M
CRISCuris Inc$30.5M

Posizioni Chiuse (8)

TickerEmittenteNozionale
MYOKMyokardia Inc$127.7M
BAXBaxter International Inc$86.6M
INCYIncyte Corp$30.0M
FIXXHomology Medicines Inc$26.9M
VXRTVaxart Inc$23.4M
ADAPYAdaptimmune Therapeutics PLC$20.9M
ALTAltimmune Inc$17.6M
AMRSQAmyris Inc$15.1M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
ILMNIllumina Inc$79.8M+106.7%-47.6%
FULCFulcrum Therapeutics Inc$15.1M+80.0%
OMOutset Med Inc$13.0M+44.5%
GHGuardant Health Inc$22.5M+24.0%+30.3%
BLUBellus Health Inc New$6.2M+23.7%
CERNCerner Corp$32.9M+22.2%
ITOSIteos Therapeutics Inc$15.1M+19.0%
VCELVericel Corp$68.2M+17.3%+52.1%

Ridotte (8)

TickerEmittenteNozionaleVar. Azioni
OSUROraSure Technologies Inc$-23.3M-91.1%
BIORProgenity Inc$-1.9M-63.6%
ITMRItamar Med Ltd$-4.8M-50.0%
INMDInmode Ltd$-3.1M-50.0%
PROFProfound Med Corp$-1.8M-50.0%
PSNLPersonalis Inc$-0.9M-50.0%
TBIOTranslate Bio Inc$3.9M-20.5%
NSTGQNanoString Technologies Inc$11.4M-15.1%
← Torna agli Hedge Fund
RTW Investments Q4 2020 13F Filing β€” Holdings & Portfolio | MarketsFN